Low levels of METTL14 predicted an unfavorable prognosis in BC, in which METTL14 expression levels significantly and positively correlated with infiltrating levels of CD4+ T cells, CD8+ T cells, neutrophils, macrophages, and DCs. Here, METTL14 is linked to breast cancer.